Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.18632/oncotarget.12822 http://scihub22266oqcxt.onion/10.18632/oncotarget.12822 C5346734!5346734 !27783993     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=27783993 &cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 251.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 251.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\27783993 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Oncotarget 2016 ; 7 (48 ): 79544-79556 Nephropedia Template TP {{tp|p=27783993 |t=2016. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3?/?-catenin signaling pathway |pdf=|usr=}}{{27783993 }} gab.com Text WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3 / -catenin signaling pathway JO: Oncotarget http://www.kidney.de/pget.php?&tw=1&pmid=27783993 #FOAvip The eradication of cancer stem cells (CSCs) is significant for cancer therapy and prevention. In this study, we evaluated WM130, a novel derivative of matrine, for its effect on CSCs using human hepatocellular carcinoma (HCC) cell lines, their sphere cells, and sorted EpCAM+ cells. We revealed that WM130 could not only inhibit proliferation and colony formation of HCC cells, but also suppress the expression of some stemness-related genes and up-regulate some mature hepatocyte marker genes, indicating a promotion of differentiation from CSCs to hepatocytes. WM130 also suppressed the proliferation of doxorubicin-resistant hepatoma cells, and markedly reduced the cells with CSC biomarker EpCAM. Moreover, WM130 suppressed HCC spheres, not only primary spheres but also subsequent spheres, indicating an inhibitory effect on self-renewal capability of CSCs. Interestingly, WM130 exhibited a remarkable inhibitory preference on HCC spheres and EpCAM+ cells rather than their parental HCC cells and EpCAM- cells respectively. In vivo, WM130 inhibited HCC xenograft growth, decreased the number of sphere-forming cells, and remarkably decreased the levels of EpCAM mRNA and protein in tumor xenografts. Better inhibitory effect was achieved by WM130 in combination with doxorubicin. Further mechanism study revealed that WM130 inhibited AKT/GSK3?/?-catenin signaling pathway. Collectively, our results suggest that WM130 remarkably inhibits hepatic CSCs, and this effect may via the down-regulation of the AKT/GSK3?/?-catenin pathway. These findings provide a strong rationale for the use of WM130 as a novel drug candidate in HCC therapy. Twit Text FOAVip WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3 / -catenin signaling pathway ????Oncotarget http://www.kidney.de/pget.php?&tw=1&pmid=27783993 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=27783993 #FOAvip English Wikipedia <ref>{{Cite pmid|27783993 }}</ref> WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3?/?-catenin signaling pathway #MMPMID27783993 Ni CX ; Qi Y ; Zhang J ; Liu Y ; Xu WH ; Xu J ; Hu HG ; Wu QY ; Wang Y ; Zhang JP Oncotarget 2016[Nov]; 7 (48 ): 79544-79556 PMID27783993 show ga The eradication of cancer stem cells (CSCs) is significant for cancer therapy and prevention. In this study, we evaluated WM130, a novel derivative of matrine, for its effect on CSCs using human hepatocellular carcinoma (HCC) cell lines, their sphere cells, and sorted EpCAM+ cells. We revealed that WM130 could not only inhibit proliferation and colony formation of HCC cells, but also suppress the expression of some stemness-related genes and up-regulate some mature hepatocyte marker genes, indicating a promotion of differentiation from CSCs to hepatocytes. WM130 also suppressed the proliferation of doxorubicin-resistant hepatoma cells, and markedly reduced the cells with CSC biomarker EpCAM. Moreover, WM130 suppressed HCC spheres, not only primary spheres but also subsequent spheres, indicating an inhibitory effect on self-renewal capability of CSCs. Interestingly, WM130 exhibited a remarkable inhibitory preference on HCC spheres and EpCAM+ cells rather than their parental HCC cells and EpCAM- cells respectively. In vivo, WM130 inhibited HCC xenograft growth, decreased the number of sphere-forming cells, and remarkably decreased the levels of EpCAM mRNA and protein in tumor xenografts. Better inhibitory effect was achieved by WM130 in combination with doxorubicin. Further mechanism study revealed that WM130 inhibited AKT/GSK3?/?-catenin signaling pathway. Collectively, our results suggest that WM130 remarkably inhibits hepatic CSCs, and this effect may via the down-regulation of the AKT/GSK3?/?-catenin pathway. These findings provide a strong rationale for the use of WM130 as a novel drug candidate in HCC therapy. |Alkaloids/*pharmacology [MESH] |Animals [MESH] |Antineoplastic Agents/*pharmacology [MESH] |Antineoplastic Combined Chemotherapy Protocols/pharmacology [MESH] |Carcinoma, Hepatocellular/*drug therapy/enzymology/genetics/pathology [MESH] |Cell Line, Tumor [MESH] |Cell Proliferation/*drug effects [MESH] |Cell Self Renewal/drug effects [MESH] |Dose-Response Relationship, Drug [MESH] |Doxorubicin/pharmacology [MESH] |Drug Resistance, Neoplasm/drug effects [MESH] |Epithelial Cell Adhesion Molecule/genetics/metabolism [MESH] |Gene Expression Regulation, Neoplastic [MESH] |Glycogen Synthase Kinase 3 beta/*metabolism [MESH] |Humans [MESH] |Inhibitory Concentration 50 [MESH] |Liver Neoplasms/*drug therapy/enzymology/genetics/pathology [MESH] |Male [MESH] |Mice, Inbred BALB C [MESH] |Mice, Nude [MESH] |Neoplastic Stem Cells/*drug effects/enzymology/pathology [MESH] |Phenotype [MESH] |Proto-Oncogene Proteins c-akt/*metabolism [MESH] |Quinolizines/*pharmacology [MESH] |Time Factors [MESH] |Tumor Burden/drug effects [MESH] |Wnt Signaling Pathway/*drug effects [MESH] |Xenograft Model Antitumor Assays [MESH]WM130 preferentially inhibits hepatic cancer stem-like cells by suppre(epmc).pdf DeepDyve Pubget Overpricing